{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:37:54Z","timestamp":1791898674620,"version":"4.3.4"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multicolor fluorescent in situ hybridization (FISH) was used to identify acquired chromosomal aberrations in 12 patients with mycosis fungoides or Se\u0301zary syndrome, the most common forms of primary cutaneous T-cell lymphoma (CTCL). The most frequently affected chromosome was 12, which showed clonal deletions or translocations with a break point in 12q21 or 12q22 in five of seven consecutive Se\u0301zary syndrome patients and a clonal monosomy in the sixth patient. The break point of a balanced translocation t(12;18)(q21;q21.2), mapped in the minimal common region of two deletions, fine mapped to 12q2. By locus-specific FISH, the translocation disrupted one gene, NAV3 (POMFIL1), a human homologue of unc-53 in Caenorhabditis elegans. A missense mutation in the remaining NAV3 allele was found in one of six cases with a deletion or translocation. With locus-specific FISH, NAV3 deletions were found in the skin lesions of four of eight (50%) patients with early mycosis fungoides (stages IA-IIA) and in the skin or lymph node of 11 of 13 (85%) patients with advanced mycosis fungoides or Se\u0301zary syndrome. Preliminary functional studies with lentiviral small interfering RNA-based NAV3 silencing in Jurkat cells and in primary lymphocytes showed enhanced interleukin 2 expression (but not CD25 expression). Thus, NAV3 may contribute to the growth, differentiation, and apoptosis of CTCL cells as well as to the skewing from Th1-type to Th2-type phenotype during disease progression. NAV3, a novel putative haploinsufficient tumor suppressor gene, is disrupted in most cases of the commonest types of CTCL and may thus provide a new diagnostic tool.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-0366","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T18:13:04Z","timestamp":1126807984000},"page":"8101-8110","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting\n                    <i>NAV3<\/i>\n                    , the Human\n                    <i>UNC-53<\/i>\n                    Homologue"],"prefix":"10.1158","volume":"65","author":[{"given":"Leena","family":"Karenko","sequence":"first","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Hahtola","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Pa\u0308ivinen","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Karhu","sequence":"additional","affiliation":[{"name":"3Laboratory of Cancer Genetics,"},{"name":"4Institute of Medical Technology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Syrja\u0308","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketta","family":"Ka\u0308hko\u0308nen","sequence":"additional","affiliation":[{"name":"5Department of Clinical Genetics, Tampere University Hospital, University of Tampere;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Nedoszytko","sequence":"additional","affiliation":[{"name":"7Department of Dermatology, Medical University of Gdansk, Gdansk, Poland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soili","family":"Kyto\u0308la\u0308","sequence":"additional","affiliation":[{"name":"3Laboratory of Cancer Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Blazevic","sequence":"additional","affiliation":[{"name":"6FIT Biotech, Ltd., Tampere, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pesonen","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nevala","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Nupponen","sequence":"additional","affiliation":[{"name":"2Oncology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Sihto","sequence":"additional","affiliation":[{"name":"2Oncology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Krebs","sequence":"additional","affiliation":[{"name":"8Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Poustka","sequence":"additional","affiliation":[{"name":"8Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Roszkiewicz","sequence":"additional","affiliation":[{"name":"7Department of Dermatology, Medical University of Gdansk, Gdansk, Poland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Saksela","sequence":"additional","affiliation":[{"name":"4Institute of Medical Technology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa\u0308rt","family":"Peterson","sequence":"additional","affiliation":[{"name":"4Institute of Medical Technology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Visakorpi","sequence":"additional","affiliation":[{"name":"3Laboratory of Cancer Genetics,"},{"name":"4Institute of Medical Technology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamari","family":"Ranki","sequence":"additional","affiliation":[{"name":"1Dermatology and Venereology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,9,15]]},"reference":[{"key":"2022061621053066900_B1","doi-asserted-by":"crossref","unstructured":"Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas, Blood\u20082005; 15: 3768\u201385.","DOI":"10.1182\/blood-2004-09-3502"},{"key":"2022061621053066900_B2","doi-asserted-by":"crossref","unstructured":"Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA\u20081988; 260: 42\u20136.","DOI":"10.1001\/jama.260.1.42"},{"key":"2022061621053066900_B3","doi-asserted-by":"crossref","unstructured":"Va\u0308keva\u0308 L, Pukkala E, Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol\u20082000; 115: 62\u20135.","DOI":"10.1046\/j.1523-1747.2000.00011.x"},{"key":"2022061621053066900_B4","doi-asserted-by":"crossref","unstructured":"Rowley JD. The critical role of chromosome translocations in human leukemias. Annu Rev Genet\u20081998; 32: 495\u2013519.","DOI":"10.1146\/annurev.genet.32.1.495"},{"key":"2022061621053066900_B5","doi-asserted-by":"crossref","unstructured":"Vega F, Orduz R, Medeiros LJ. Chromosomal translocations and their role in the pathogenesis of non-Hodgkin's lymphomas. Pathology\u20082002; 34: 397\u2013409.","DOI":"10.1080\/0031302021000009306"},{"key":"2022061621053066900_B6","doi-asserted-by":"crossref","unstructured":"Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer\u20081982; 50: 1539\u201353.","DOI":"10.1002\/1097-0142(19821015)50:8<1539::AID-CNCR2820500814>3.0.CO;2-G"},{"key":"2022061621053066900_B7","doi-asserted-by":"crossref","unstructured":"Karenko L, Hyytinen E, Sarna S, Ranki A. Chromosomal abnormalities in cutaneous T-cell lymphoma (CTCL) and its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol\u20081997; 108: 22\u20139.","DOI":"10.1111\/1523-1747.ep12285617"},{"key":"2022061621053066900_B8","doi-asserted-by":"crossref","unstructured":"Karenko L, Ka\u0308hko\u0308nen M, Hyytinen E-R, Lindlo\u0308f M, Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in the Se\u0301zary syndrome detected by comparative genomic hybridization. J Invest Dermatol\u20081999; 112: 392\u20135.","DOI":"10.1038\/sj.jid.5600444"},{"key":"2022061621053066900_B9","doi-asserted-by":"crossref","unstructured":"Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. Molecular cytogenetic characterization of Se\u0301zary syndrome. Genes Chromosomes Cancer\u20082003; 36: 250\u201360.","DOI":"10.1002\/gcc.10152"},{"key":"2022061621053066900_B10","doi-asserted-by":"crossref","unstructured":"Karenko L, Sarna S, Ka\u0308hko\u0308nen M, Ranki A. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol\u20082003; 148: 55\u201364.","DOI":"10.1046\/j.1365-2133.2003.05116.x"},{"key":"2022061621053066900_B11","doi-asserted-by":"crossref","unstructured":"Karenko L, Nevala H, Raatikainen M, Franssila K, Ranki A. Chromosomally clonal T cells in the skin, blood or lymph nodes of two Se\u0301zary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-\u03b3. J Invest Dermatol\u20082001; 116: 188\u201393.","DOI":"10.1046\/j.1523-1747.2001.00207.x"},{"key":"2022061621053066900_B12","unstructured":"ISCN. An international system for human cytogenetic nomenclature. In: Mitelman F, editor. Basel (Switzerland): S. Karger; 1995."},{"key":"2022061621053066900_B13","doi-asserted-by":"crossref","unstructured":"Zhang KZ, Westberg JA, Holtta E, Andersson LC. BCL2 regulates neural differentiation. Proc Natl Acad Sci U S A\u20081996; 93: 4504\u20138.","DOI":"10.1073\/pnas.93.9.4504"},{"key":"2022061621053066900_B14","doi-asserted-by":"crossref","unstructured":"Coy JF, Wiemann S, Bechmann I, et al. Pore membrane and\/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms. Gene\u20082002; 290: 73\u201394.","DOI":"10.1016\/S0378-1119(02)00567-X"},{"key":"2022061621053066900_B15","doi-asserted-by":"crossref","unstructured":"Schro\u0308ck E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science\u20081996; 273: 494\u20137.","DOI":"10.1126\/science.273.5274.494"},{"key":"2022061621053066900_B16","doi-asserted-by":"crossref","unstructured":"Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet\u20081996; 12: 368\u201375.","DOI":"10.1038\/ng0496-368"},{"key":"2022061621053066900_B17","doi-asserted-by":"crossref","unstructured":"Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi OP, Isola JJ. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry\u20081994; 16: 93\u20139.","DOI":"10.1002\/cyto.990160202"},{"key":"2022061621053066900_B18","doi-asserted-by":"crossref","unstructured":"Sihto H, Sarlomo-Rikala M, Tynninen O, et al. KIT and platelet-derived growth factor receptor \u03b1 tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol\u20082005; 23: 49\u201357.","DOI":"10.1200\/JCO.2005.02.093"},{"key":"2022061621053066900_B19","doi-asserted-by":"crossref","unstructured":"Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol\u20081997; 15: 871\u20135.","DOI":"10.1038\/nbt0997-871"},{"key":"2022061621053066900_B20","doi-asserted-by":"crossref","unstructured":"Linja MK, Porkka KP, Kang KJ, et al. Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res\u20082004; 10: 1032\u201340.","DOI":"10.1158\/1078-0432.CCR-0990-3"},{"key":"2022061621053066900_B21","doi-asserted-by":"crossref","unstructured":"Higgins, MJ, Hansen HF, Cavenee WK, Lalande M. Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus. Mol Cell Biol\u20081989; 9: 1\u20135.","DOI":"10.1128\/mcb.9.1.1-5.1989"},{"key":"2022061621053066900_B22","doi-asserted-by":"crossref","unstructured":"Maes T, Barcelo\u0301 A, Buesa C. Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans. Genomics\u20082002; 80: 21\u201330.","DOI":"10.1006\/geno.2002.6799"},{"key":"2022061621053066900_B23","doi-asserted-by":"crossref","unstructured":"Merrill RA, Plum LA, Kaiser ME, Clagett-Dame M. A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos. Proc Natl Acad Sci U S A\u20082002; 99: 3422\u20137.","DOI":"10.1073\/pnas.052017399"},{"key":"2022061621053066900_B24","doi-asserted-by":"crossref","unstructured":"Stringham E, Pujol N, Vandekerckhove J, Bogaert T. unc53 controls longitudinal migration in C. elegans. Development\u20082002; 129: 3367\u201379.","DOI":"10.1242\/dev.129.14.3367"},{"key":"2022061621053066900_B25","doi-asserted-by":"crossref","unstructured":"Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets\u20082004; 4: 345\u201354.","DOI":"10.2174\/1568009043332998"},{"key":"2022061621053066900_B26","doi-asserted-by":"crossref","unstructured":"Fahrenkrog B, Aebi U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat Rev Mol Cell Biol\u20082003; 4: 757\u201366.","DOI":"10.1038\/nrm1230"},{"key":"2022061621053066900_B27","doi-asserted-by":"crossref","unstructured":"Ishiguro H, Shimokawa T, Tsunoda T, et al. Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas. Oncogene\u20082002; 21: 6387\u201394.","DOI":"10.1038\/sj.onc.1205751"},{"key":"2022061621053066900_B28","doi-asserted-by":"crossref","unstructured":"Nakayama H. RecQ family helicases: roles as tumor suppressor proteins [review]. Oncogene\u20082002; 21: 9008\u201321.","DOI":"10.1038\/sj.onc.1205959"},{"key":"2022061621053066900_B29","doi-asserted-by":"crossref","unstructured":"Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatelite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood\u20082000; 95: 2937\u201342.","DOI":"10.1182\/blood.V95.9.2937.009k15_2937_2942"},{"key":"2022061621053066900_B30","doi-asserted-by":"crossref","unstructured":"Limon J, Nedoszytko B, Brozek I, et al. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocyte of five cases with Se\u0301zary syndrome. Cancer Genet Cytogenet\u20081995; 83: 75\u201381.","DOI":"10.1016\/0165-4608(94)00292-4"},{"key":"2022061621053066900_B31","doi-asserted-by":"crossref","unstructured":"Kaltoft K, Hansen BH, Thestrup-Pedersen K. Cytognetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol Clin\u20081994; 12: 295\u2013304.","DOI":"10.1016\/S0733-8635(18)30176-1"},{"key":"2022061621053066900_B32","doi-asserted-by":"crossref","unstructured":"Hickson ID. RecQ Helicases: Caretakers of the genome. Review. Nat Rev Cancer\u20082003; 3: 169\u201378.","DOI":"10.1038\/nrc1012"},{"key":"2022061621053066900_B33","doi-asserted-by":"crossref","unstructured":"Sherr CJ. Principles of tumor suppression. Review. Cell\u20082004; 116: 235\u201346.","DOI":"10.1016\/S0092-8674(03)01075-4"},{"key":"2022061621053066900_B34","doi-asserted-by":"crossref","unstructured":"Peeters PJ, Baker A, Goris I, et al. Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. Dev Brain Res\u20082004; 150: 89\u2013101.","DOI":"10.1016\/j.devbrainres.2004.03.004"},{"key":"2022061621053066900_B35","doi-asserted-by":"crossref","unstructured":"Navas IC, Ortiz-Romero PL, Villuendas R, et al. p16INK4a gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol\u20082000; 156: 1565\u201372.","DOI":"10.1016\/S0002-9440(10)65028-6"},{"key":"2022061621053066900_B36","doi-asserted-by":"crossref","unstructured":"Garatti SA, Roscetti E, Trecca D, Fracciolla NS, Neri A, Berti E. bcl-1, bcl-2, p53,c-myc, and lyt-10 analysis in cutaneous T-cell lymphomas. Recent Results Cancer Res\u20081995; 139: 249\u201361.","DOI":"10.1007\/978-3-642-78771-3_19"},{"key":"2022061621053066900_B37","doi-asserted-by":"crossref","unstructured":"Scarisbrick JJ, Woolford AJ, Calonje E, et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Se\u0301zary syndrome. J Invest Dermatol\u20082002; 118: 493\u20139.","DOI":"10.1046\/j.0022-202x.2001.01682.x"},{"key":"2022061621053066900_B38","doi-asserted-by":"crossref","unstructured":"Mao X, Lillington D, Scarisbrick JJ, et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: Identification of common genetic alterations in Se\u0301zary syndrome and mycosis fungoides. Br J Dermatol\u20082002; 147: 464\u201375.","DOI":"10.1046\/j.1365-2133.2002.04966.x"},{"key":"2022061621053066900_B39","doi-asserted-by":"crossref","unstructured":"Smith KA. Interleukin-2: inception, impact, and implications. Science\u20081988; 240: 1169\u201376.","DOI":"10.1126\/science.3131876"},{"key":"2022061621053066900_B40","doi-asserted-by":"crossref","unstructured":"Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Se\u0301zary syndrome expresses a Th2-type profile. J Invest Dermatol\u20081994; 103: 29\u201333.","DOI":"10.1111\/1523-1747.ep12388985"},{"key":"2022061621053066900_B41","doi-asserted-by":"crossref","unstructured":"Lee BN, Duvic M, Tang CK, et al. Dysregulated synthesis of intracellular type 1 and type 2 cytokine by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol\u20081999; 1: 79\u201384.","DOI":"10.1128\/CDLI.6.1.79-84.1999"},{"key":"2022061621053066900_B42","doi-asserted-by":"crossref","unstructured":"Cote-Sierra J, Foucras G, Guo L, et al. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A\u20082005; 101: 3880\u20135.","DOI":"10.1073\/pnas.0400339101"},{"key":"2022061621053066900_B43","doi-asserted-by":"crossref","unstructured":"Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res\u20082004; 10: 5587\u201394.","DOI":"10.1158\/1078-0432.CCR-0721-03"},{"key":"2022061621053066900_B44","unstructured":"Mitchell TJ, Whittaker SJ, John S. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Se\u0301zary syndrome. Cancer Res\u20082003; 63: 9048\u201354."},{"key":"2022061621053066900_B45","doi-asserted-by":"crossref","unstructured":"Eriksen KW, Kaltoft K, Mikkelsen G, et al. Constitutive STAT3-activation in Se\u0301zary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Se\u0301zary cells. Leukemia\u20082001; 15: 787\u201393.","DOI":"10.1038\/sj.leu.2402093"},{"key":"2022061621053066900_B46","doi-asserted-by":"crossref","unstructured":"Moriggl R, Topham DJ, Teglund S, et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity\u20081999; 10: 249\u201359.","DOI":"10.1016\/S1074-7613(00)80025-4"},{"key":"2022061621053066900_B47","doi-asserted-by":"crossref","unstructured":"Nakajima H, Liu XW, Wynshaw-Boris A, et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-medated IL-2 receptor \u03b1 chain induction. Immunity\u20081997; 7: 691\u2013701.","DOI":"10.1016\/S1074-7613(00)80389-1"},{"key":"2022061621053066900_B48","doi-asserted-by":"crossref","unstructured":"Frauwirth KA, Thompson GB. Activation and inhibition of lymphocytes by costimulation [review]. J Clin Invest\u20082002; 109: 295\u20139.","DOI":"10.1172\/JCI0214941"},{"key":"2022061621053066900_B49","doi-asserted-by":"crossref","unstructured":"Moghal N, Sternberg PW. The epidermal growth factor system in Caenorhabditis elegans. Exp Cell Res\u20082003; 284: 150\u20139.","DOI":"10.1016\/S0014-4827(02)00097-6"},{"key":"2022061621053066900_B50","doi-asserted-by":"crossref","unstructured":"Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whittaker SJ. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides, J Invest Dermatol\u20082000; 114: 117\u201321.","DOI":"10.1046\/j.1523-1747.2000.00830.x"},{"key":"2022061621053066900_B51","doi-asserted-by":"crossref","unstructured":"Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor \u03b3 polymerase chain reaction assay, J Invest Dermatol\u20082000; 115: 254\u20139.","DOI":"10.1046\/j.1523-1747.2000.00040.x"},{"key":"2022061621053066900_B52","doi-asserted-by":"crossref","unstructured":"Muche JM, Karenko L, Gellrich S, et al. Cellular coincidence of clonal T-cell receptor rearrangements and complex clonal chromosomal aberrations\u2014a hallmark of malignancy in cutaneous T-cell lymphoma? J Invest Dermatol\u20082004; 122: 574\u20138.","DOI":"10.1111\/j.0022-202X.2004.22303.x"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/18\/8101\/2533131\/8101-8110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/18\/8101\/2533131\/8101-8110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:34:58Z","timestamp":1655404498000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/18\/8101\/518185\/Primary-Cutaneous-T-Cell-Lymphomas-Show-a-Deletion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":52,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2005,9,15]]},"published-print":{"date-parts":[[2005,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-0366","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22363524.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363530","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363530.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363527.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363527","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363524","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6493752.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6493752","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]}}}